Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Giovannucci E, Michaud D.

Gastroenterology. 2007 May;132(6):2208-25. Review.

PMID:
17498513
2.

Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.

Giovannucci E.

Am J Clin Nutr. 2007 Sep;86(3):s836-42. Review.

PMID:
18265477
3.

Diabetes mellitus type 2 - an independent risk factor for cancer?

Grote VA, Becker S, Kaaks R.

Exp Clin Endocrinol Diabetes. 2010 Jan;118(1):4-8. doi: 10.1055/s-0029-1243193. Epub 2010 Feb 1. Review.

PMID:
20127570
4.

Diabetes, insulin, and risk of cancer.

Schiel R, Beltschikow W, Steiner T, Stein G.

Methods Find Exp Clin Pharmacol. 2006 Apr;28(3):169-75. Review.

PMID:
16810343
5.

Energy intake, physical activity, energy balance, and cancer: epidemiologic evidence.

Pan SY, DesMeules M.

Methods Mol Biol. 2009;472:191-215. doi: 10.1007/978-1-60327-492-0_8. Review.

PMID:
19107434
6.

Type 2 diabetes and cancer: what is the connection?

Cannata D, Fierz Y, Vijayakumar A, LeRoith D.

Mt Sinai J Med. 2010 Mar-Apr;77(2):197-213. doi: 10.1002/msj.20167. Review.

PMID:
20309918
7.

[Correlations of insulin resistance and neoplasms].

Suba Z, UjpƔl M.

Magy Onkol. 2006;50(2):127-35. Epub 2006 Aug 4. Review. Hungarian.

8.

Obesity and prostate cancer.

O'Malley RL, Taneja SS.

Can J Urol. 2006 Apr;13 Suppl 2:11-7. Review.

PMID:
16672123
9.

Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence.

Xue F, Michels KB.

Am J Clin Nutr. 2007 Sep;86(3):s823-35. Review.

PMID:
18265476
10.

[Tumours of kidneys, urinary bladder and prostate in obesity and diabetes].

Svacina S.

Vnitr Lek. 2008 May;54(5):464-7. Review. Czech.

PMID:
18630627
11.

Obesity and prostate cancer: making sense out of apparently conflicting data.

Freedland SJ, Platz EA.

Epidemiol Rev. 2007;29:88-97. Epub 2007 May 3. Review.

PMID:
17478439
12.

Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome.

Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S, Mohanty P.

Curr Mol Med. 2008 Dec;8(8):816-28. Review.

PMID:
19075678
13.

Modifiable risk factors for colon cancer.

Giovannucci E.

Gastroenterol Clin North Am. 2002 Dec;31(4):925-43. Review.

PMID:
12489270
14.

Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer.

Richardson LC, Pollack LA.

Nat Clin Pract Oncol. 2005 Jan;2(1):48-53. Review.

PMID:
16264856
15.

Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.

Vona-Davis L, Howard-McNatt M, Rose DP.

Obes Rev. 2007 Sep;8(5):395-408. Review.

PMID:
17716297
16.

Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence.

LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S.

Exp Clin Endocrinol Diabetes. 2008 Sep;116 Suppl 1:S4-6. doi: 10.1055/s-2008-1081488. Epub 2008 Sep 5. Review.

PMID:
18777452
17.

Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.

Sciacca L, Vigneri R, Tumminia A, Frasca F, Squatrito S, Frittitta L, Vigneri P.

Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):808-15. doi: 10.1016/j.numecd.2013.05.006. Epub 2013 Aug 7. Review.

PMID:
23932729
18.

Insulin resistance and cancer: epidemiological evidence.

Tsugane S, Inoue M.

Cancer Sci. 2010 May;101(5):1073-9. doi: 10.1111/j.1349-7006.2010.01521.x. Epub 2010 Feb 3. Review.

19.

Obesity and prostate cancer: epidemiology and clinical implications.

Buschemeyer WC 3rd, Freedland SJ.

Eur Urol. 2007 Aug;52(2):331-43. Epub 2007 May 2. Review.

PMID:
17507151
20.

Beta-cell function and mass in type 2 diabetes.

Larsen MO.

Dan Med Bull. 2009 Aug;56(3):153-64.

PMID:
19728971

Supplemental Content

Support Center